JPM MerQube vol target play crosses US$200m in sales

The volatility controlled proprietary underlying developed by US start-up index provider MerQube has now amassed US$196m in structured product sales across 142 structures, SRP data shows. The index was exclusively licensed to J.P. Morgan in mid-July 2021. The US investment bank also led a Series A funding worth US$5m for MerQube to drive its international expansion and accelerate platform development . To-date, the best-selling structure tied to the MerQube US Tech+ Vol Advantage Index is the